Novo Nordisk A/S (NONOF)
47.00
+0.19
(+0.41%)
USD |
OTCM |
Aug 24, 16:00
Novo Nordisk Max Drawdown (5Y) : 75.56% for July 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| July 31, 2026 | 75.56% |
| June 30, 2026 | 75.56% |
| May 31, 2026 | 75.56% |
| April 30, 2026 | 75.56% |
| March 31, 2026 | 75.56% |
| February 28, 2026 | 73.86% |
| January 31, 2026 | 68.84% |
| December 31, 2025 | 68.84% |
| November 30, 2025 | 68.84% |
| October 31, 2025 | 68.83% |
| September 30, 2025 | 68.83% |
| August 31, 2025 | 68.83% |
| July 31, 2025 | 67.12% |
| June 30, 2025 | 60.41% |
| May 31, 2025 | 60.41% |
| April 30, 2025 | 60.41% |
| March 31, 2025 | 53.29% |
| February 28, 2025 | 47.31% |
| January 31, 2025 | 47.03% |
| December 31, 2024 | 42.88% |
| November 30, 2024 | 31.79% |
| October 31, 2024 | 26.54% |
| September 30, 2024 | 24.80% |
| August 31, 2024 | 24.80% |
| July 31, 2024 | 24.80% |
| Date | Value |
|---|---|
| June 30, 2024 | 24.80% |
| May 31, 2024 | 24.80% |
| April 30, 2024 | 24.80% |
| March 31, 2024 | 24.80% |
| February 29, 2024 | 24.80% |
| January 31, 2024 | 24.80% |
| December 31, 2023 | 24.80% |
| November 30, 2023 | 24.80% |
| October 31, 2023 | 24.80% |
| September 30, 2023 | 27.40% |
| August 31, 2023 | 27.40% |
| July 31, 2023 | 27.40% |
| June 30, 2023 | 27.40% |
| May 31, 2023 | 27.40% |
| April 30, 2023 | 27.40% |
| March 31, 2023 | 27.40% |
| February 28, 2023 | 27.40% |
| January 31, 2023 | 27.40% |
| December 31, 2022 | 27.40% |
| November 30, 2022 | 27.40% |
| October 31, 2022 | 27.40% |
| September 30, 2022 | 27.40% |
| August 31, 2022 | 27.40% |
| July 31, 2022 | 27.40% |
| June 30, 2022 | 27.61% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Eli Lilly & Co. | 34.47% |
| ALK-Abello A/S | 66.02% |
| H. Lundbeck A/S | -- |
| Dr. Reddy's Laboratories Ltd. | 35.89% |
| Neumora Therapeutics, Inc. | -- |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -8.512 |
| Beta (5Y) | 0.7656 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 38.50% |
| Historical Sharpe Ratio (5Y) | -0.0381 |
| Historical Sortino (5Y) | -0.0526 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 20.17% |